# Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment

> **NCT03780621** · PHASE1 · COMPLETED · sponsor: **EuroPharma, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Cognitive Impairment, Mild

## Interventions

- **DIETARY_SUPPLEMENT:** Andrographis and Withania
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03780621
- **Lead sponsor:** EuroPharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03780621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03780621, "Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT03780621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*